ArticleDiabetes & metabolism journal2026

Risk Factors and Survival Outcomes of Immune Checkpoint Inhibitor-Induced Type 1 Diabetes Mellitus: A Retrospective Cohort Study.

Sang-Hyeok Go et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.